Bio/Pharm and Building Codes: Planning and Designing for Safety and Performance

Wednesday, January 30 2013
3:30 pm – 6:30 pm

This event was posted by The Richmond Group, Inc.

Location: Genzyme Corporate Headquarters, 675 Kendall Street, Cambridge, MA

IFMA R&D Council presents: Bio/Pharm and Building Codes: Planning and Designing for Safety and Performance From a fire protection, chemical control and life safety standpoint, regulatory agencies impact everything from the storage and use of hazardous materials to the relationship of lab and office spaces. This presentation considers how these requirements may affect not only capital projects, but also how they impact operational decisions that are being made by facilities owners and tenants. Issues to be discussed include: What building and site fire protection and life safety features enter into the decision making for design or selection of an appropriate building for bio/pharma occupancy? What are the limitations for location of bench scale, pilot scale and large scale processing in existing and new buildings? How do the latest changes in the International Building and Fire Codes impact the placement of Group B, F and H occupancies? Do these changes allow for greater flexibility for end users? How do the code requirements impact capital costs for bio/pharma facilities? What are the approaches for marketing laboratory and process space to prospective tenants, taking into consideration whether an existing or new building can support the biology and chemistry functions being proposed? What factors are important on the operations side, as users occupy buildings that are subject to the allowances in the codes for chemical storage and use? Panelists: Jonathan M. Eisenberg, P.E., Vice President Rolf Jensen & Associates, Inc. William Harris, Principal Perkins & Will Steve Carbonneau, President The Richmond Group

Share MassBio